R Street Comments on the FDA-CTP Strategic Plan

Food and Drug Administration – Center for Tobacco Products5630 Fishers Lane, Rm. 1061Rockville, MD 20852 Re: Docket No. FDA–2023–N–2873 Dear Dr. Brian King, Director of the Food and Drug Administration’s Center for Tobacco Products, The R Street Institute (R Street) respectfully submits comments on the development of the Food and Drug Administration’s (FDA’s) Center for … Continue reading R Street Comments on the FDA-CTP Strategic Plan